Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/49024
Authors: 
Granlund, David
Rudholm, Niklas
Year of Publication: 
2011
Citation: 
[Journal:] Advances in Management & Applied Economics [ISSN:] 1792-7552 [Volume:] 1 [Year:] 2011 [Issue:] 1 [Pages:] 1-14
Abstract: 
In October 2002, a substitution reform was introduced in the Swedish pharmaceuticals market. In this paper, the effects of increased price competition due to the reform on the entry of new pharmaceutical products were studied. The results show that the reform did affect the entry behavior of generic manufacturers as they became more prone to enter new package sizes into the market after the reform, but also that there is considerable heterogeneity in entry behavior between different ATC-code groups for both brand name and generic products.
Subjects: 
pharmaceutical industry
generic competition
generic drugs
brand name drugs
JEL: 
D80
D83
L65
I11
Document Type: 
Article

Files in This Item:
File
Size
167.76 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.